News | October 03, 2013

Radial Access Advertised to Attract Patients at Bethesda Heart Hospital

Bethesda’s interventional cardiologists offer the latest advancements in cardiac catheterization: transradial artery catheterization

Radial access cath lab bethesda transradial artery

October 3, 2013 — While 95 percent of cardiac catheterizations in the United States are done through the groin, physicians at Bethesda Heart Hospital are utilizing special training to offer patients a safer, more comfortable procedure.

Transradial artery catheterization is a less invasive endovascular technique that gives physicians access to the heart through the patient’s wrist rather than through the femoral artery in the groin. Using slightly smaller equipment through the radial artery, physicians can accomplish the same goals with fewer complications and a more satisfying patient experience.

“Patients who have had catheterizations done both ways were impressed by the comfort and ease of the radial approach,” said Michael Metzger, M.D. and interventional cardiologist. “A patient can get up from the table. They’re not spending hours lying down with compression on the groin as is required with the femoral approach.”

The femoral approach carries small but significant risks of complications, such as heavy bleeding, arterial damage, bruising or other problems. The transradial method is steadily gaining momentum because it all but eliminates these complications. Jay Midwall, M.D., interventional cardiologist, believes that in the next 10 years, between 30 and 40 percent of all cardiac catheterizations are likely to be done through the radial artery.

“It takes more time, skill and special training,” explained Midwall, adding that the radial procedure is currently prevalent in Europe and the Middle East. “As doctors in the U.S. adopted this technique, two things happened: one, patients preferred it and two, a number of studies showed it was safer with less bleeding.”

Blood flow isn’t compromised during transradial artery catheterization. Anatomical differences or medical conditions occasionally eliminate certain patients as candidates for the radial approach, but most can easily opt for this method. Regardless, both sites are prepped before a procedure begins to offer cardiologists options in case the femoral approach is needed, which is rare, according to Anil Verma, M.D. and interventional cardiologist.

The radial technique reduces the risk of bleeding and damage to blood vessels, and patients are able to stand up and walk more quickly following the procedure. These factors combine to help minimize the length of a patient’s hospital stay and to reduce costs, physicians said.

“If we have complex procedures... that require large catheters, then we have to go through the femoral artery,” Verma said, adding that these include aortic valve implant and intra-aortic balloon pumps. “But in the last 10 years, radial has caught on more and more.”

Support for the radial approach at Bethesda Heart Hospital was early and enduring, noted Metzger.

“When I chose to do transradial catheterizations four years ago, the implementation had a significant learning curve for the team,” he adds. “Now, with 40 percent of Bethesda’s procedures being performed transradially, the staff enthusiastically supports this new approach, recognizing the long-term benefits to our patients.”

For more information: www.bethesdaheart.org

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init